Theratechnologies Inc. THTX

NAS: THTX | ISIN: CA88338H1001   14/11/2024
1,210 USD (-0,82%)
(-0,82%)   14/11/2024

Toronto Stock Exchange, Theratechnologies Inc., View From The C-Suite

TORONTO, Aug. 21, 2023 /PRNewswire/ - Paul Lévesque, President and Chief Executive Officer, Hamilton Thorne Ltd. ("Theratechnologies", the "Company", or "we") (TSX: TH) shares his Company's story in an interview with TMX Group.

The View From The C-Suite video interview series highlights the unique perspectives of listed companies on Toronto Stock Exchange and TSX Venture Exchange. Videos provide insight into how company executives think in the current business environment. To see the latest View From The C-Suite visit https://www.tmxmoney.com/en/csuite.html.

About Theratechnologies Inc. (TSX: TH)

Theratechnologies (TSX: TH) (NASDAQ: THTX) is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs. Further information about Theratechnologies is available on the Company's website at www.theratech.com, on SEDAR at www.sedar.com and on EDGAR at www.sec.gov.

CNW sponsored announcement. To learn more visit www.newswire.ca.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/toronto-stock-exchange-theratechnologies-inc-view-from-the-c-suite-301905942.html

SOURCE Toronto Stock Exchange

Mijn selecties